Unapproved products the fda has forced off the market since the policy was announced include injectable colchicine, topical papain, timed-release guaifenesin and trimethobenzamide hydrochloride suppositories, plus some versions of codeine sulfate, carbinoxamine, ergotamine and hydrocodone.
Read more